CHANG; Hui-Fang
Patent Applications and Registrations
Patent applications and USPTO patent grants for CHANG; Hui-Fang.The latest application filed is for "irak4 inhibitors".
- CHANG; Hui-Fang - Gothenburg SE
- Chang; Hui-Fang - Wilmington DE
- Chang; Hui-Fang - Taipei TW
| Patent | Date |
|---|---|
| Irak4 Inhibitors App 20220185817 - TERSTIEGE; Ina ; et al. | 2022-06-16 |
| Cinnoline Compounds for the Treatment of Anxiety, Cognitive and Mood Disorders App 20110144331 - Chapdelaine; Marc J. ; et al. | 2011-06-16 |
| Nicotinic Acetylcholine Receptor Ligands 101 App 20110136804 - Chang; Hui-Fang ; et al. | 2011-06-09 |
| Thienyl Compounds App 20110124672 - Chang; Hui-Fang ; et al. | 2011-05-26 |
| Nicotinic acetylcholine receptor ligands 101 Grant 7,842,803 - Chang , et al. November 30, 2 | 2010-11-30 |
| Oxazolidinone nicotinic acetylcholine receptor agonists Grant 7,514,567 - Chang , et al. April 7, 2 | 2009-04-07 |
| Compounds and Uses Thereof App 20090036454 - Chapdelaine; Marc J. ; et al. | 2009-02-05 |
| Compounds and Uses Thereof App 20090018112 - Chapdelaine; Marc J. ; et al. | 2009-01-15 |
| Compounds and Uses Thereof - 848 App 20080318943 - Chang; Hui-Fang ; et al. | 2008-12-25 |
| Compounds and uses thereof Grant 7,465,795 - Chapdelaine , et al. December 16, 2 | 2008-12-16 |
| Compounds and uses thereof Grant 7,425,556 - Chapdelaine , et al. September 16, 2 | 2008-09-16 |
| Heterocyclic compounds Grant 7,417,050 - Chang , et al. August 26, 2 | 2008-08-26 |
| Furyl compounds Grant 7,417,049 - Chang , et al. August 26, 2 | 2008-08-26 |
| Nicotinic Acetylcholine Receptor Ligands 101 App 20080139600 - Chang; Hui-Fang ; et al. | 2008-06-12 |
| Nicotinic Acetylcholine Receptor Ligands App 20080113983 - Chapdelaine; Marc ; et al. | 2008-05-15 |
| Compounds and Uses Thereof App 20070142382 - Chapdelaine; Marc J. ; et al. | 2007-06-21 |
| Compounds and Uses Thereof App 20070142328 - Chapdelaine; Marc J. ; et al. | 2007-06-21 |
| Thienyl Compounds App 20070142419 - Chang; Hui-Fang ; et al. | 2007-06-21 |
| Thienyl compounds Grant 7,186,836 - Chang , et al. March 6, 2 | 2007-03-06 |
| Spiro '1-azabicyclo' 2.2.2! octan-3,5'-oxazolidin - 2'-one! derivatives with affinity to the alpha7 nicotinic acetylcholine receptor App 20060154945 - Chang; Hui-Fang ; et al. | 2006-07-13 |
| Furyl compounds App 20050176745 - Chang, Hui-Fang ; et al. | 2005-08-11 |
| Thienyl compounds App 20050171106 - Chang, Hui-Fang ; et al. | 2005-08-04 |
| Heterocyclic compounds App 20050131003 - Chang, Hui-Fang ; et al. | 2005-06-16 |
| Oral cisapride dosage forms with an extended duration Grant 6,221,396 - Chao , et al. April 24, 2 | 2001-04-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 